- Keytruda patients are taking to social media to complain about Merck’s patient assistance program.
- Among the complaints are “closed offices” and wait times in the hours.
- Patients prefer BMS’s patient assistance which they see as more responsine.
“Sharon was given a few months to live. One year later, she’s here to tell her story”. That’s the headline of the print ad for Merck’s Keytruda and Oncologists are not happy with it. Continue reading
KEY TAKEAWAY: Merck is leveraging the new approval for Keytruda via enhanced PR but the PR hype is quite different from the realities of the market. Continue reading